stars 1 stars 2 stars 3

Arclio is a clinical-evidence platform for biopharma. It gives regulatory, clinical, and biostatistics teams FDA-defensible answers from their trial data in 30 seconds, not three days. Unlike tools that only show where a number came from, Arclio proves it correct and unaltered through deterministic, re-runnable computations on a tamper-evident evidence chain. The agent runs entirely inside your own infrastructure — no data ever moves. It produces publication-grade charts and an FDA readiness scorecard across efficacy, safety, data quality, competitive positioning, and biomarkers.

Website https://www.arclio.ai/
Employees 3 (3 on RocketReach)
Founded 2025
Industry Technology, Information and Internet

Arclio Questions

Jacques Kotze is the Founder of Arclio.

3 people are employed at Arclio.

Arclio is based in New York, New York.

Top Arclio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users